ANRO
Alto Neuroscience, Inc.Closed22.09−2.06 −8.53%USD
NYSE · as of Oct 13, 16:00 ET · 20m delayAfter hours 22.30 +0.95%
Open
24.04
Prev close
24.15
Day range
22.0724.20
52-week range
5.5637.48
Volume
663.30K1.29×
Mkt cap
866.86M
P/E ttm
—
Fwd P/E
-6.72
EPS ttm
-2.31
Div yield
0.00%
Earnings
—
From 52w high
−41.06%
ANRO compared with peers
ANRO vs Peers
5 peers · related companies in the same sector
Forward P/E
−6.7×
peer median —
EV/EBITDA
−7.4×
peer median 0.3×
Price / sales
—
peer median 478.8×
Net margin
0.0%
peer median 0.0%· +0.0 pts
Revenue growth
—
peer median —
Comparison
| Company | Mkt cap | Today | Fwd P/E | P/E | PEG | P/S | P/B | EV/EBITDA | EV/Sales | Div yield | Remove |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ANROAlto Neuroscience, Inc. | 866.86M | −8.5% | −6.7× | — | — | — | 3.5× | −7.4× | — | 0.0% | |
| CGONCG Oncology, Inc. | 5.53B | −1.2% | −20.7× | — | — | 888.1× | 5.4× | −18.1× | 724.4× | 0.0% | |
| RAPPRapport Therapeutics, Inc. | 1.39B | −3.8% | −5.7× | — | — | 69.5× | 3.3× | −6.3× | 48.2× | 0.0% | |
| AVBPArriVent BioPharma, Inc. | 793.36M | −2.2% | −4.2× | — | — | — | 2.1× | — | — | 0.0% | |
| KYTXKyverna Therapeutics, Inc. | 356.84M | −7.1% | −1.8× | — | — | — | 2.1× | −1.2× | — | 0.0% | |
| ARTVArtiva Biotherapeutics, Inc. | 307.52M | −7.1% | −2.4× | — | — | — | 0.9× | 0.3× | — | 0.0% | |
| Peer median | 793.36M | −3.8% | — | — | — | 478.8× | 2.1× | 0.3× | 386.3× | 0.0% |
Positioning
Bubble size is market cap. A name above the cluster costs more for the same growth or margin.